Skip to content
Free shipping over $150 · $50 minimum order · Ships in 1–3 business days · COA for every lot
Log in
Peptides 99.82% purity Research Use Only · Not for Human or Veterinary Consumption

Tesamorelin 10 mg

Tesamorelin 10 mg supplied as a lyophilised vial. Tested at 99.82% purity by an independent laboratory. Certificate published under lot COA8653.

Purity
99.82% HPLC
Mol. weight
5136 g/mol
Current lot
COA8653 COA →
$84.99 $59.99 per vial, 10 mg

Quantity — volume pricing

30 ml +$14.99
In stock Lot COA8653 View COA → $50 minimum order

At a glance

98+

Third-party purity

Every lot has a certificate from an independent laboratory, typically for HPLC purity and identity.

1–3

Business days to dispatch

Orders are usually prepared for shipment within 1–3 business days, then tracked end to end.

COA

Published before purchase

Read the latest certificate for the compound before you place the order, not after.

Certificate of analysis

The laboratory's report for the current lot

The certificate of analysis an independent laboratory issued for the lot listed here: typically purity by HPLC and identity, and endotoxins where the laboratory tested them.

Lot COA8653
Purity 99.82% HPLC
Identity Confirmed by LC-MS/MS · 10.64 mg per vial
Laboratory Bioviridian
Tested September 2, 2026

Specification

Purity
99.82% by HPLC
CAS number
218949-48-5
Molecular weight
5136 g/mol
Molecular formula
C221H366N72O67S
Physical form
Lyophilised white powder
Net quantity
10 mg per vial
Current lot
COA8653
Tested by
Bioviridian
SKU
PFL-TESAMORELIN-10-MG

Storage & reconstitution

Before opening

Lyophilised powder is stable at ambient temperature in transit. On arrival, keep sealed vials refrigerated at 2–8 °C, dry and dark. For storage beyond three months, keep at −20 °C.

Reconstitution

Follow your laboratory's own protocol.

After reconstitution

Refrigerate at 2–8 °C and protect from light. Use within 30 days. Discard if the solution becomes cloudy or discoloured.

For laboratory research use only. Not for human or veterinary consumption. Not a drug or dietary supplement.

Research record

Three characterised lines of work

Tesamorelin is a synthetic analog of growth hormone–releasing hormone (GHRH) designed to interact with the GHRH receptor and support research into endocrine and metabolic signaling pathways. Structurally derived from the endogenous GHRH sequence, it is widely studied in preclinical and translational models examining growth hormone axis regulation, receptor-mediated signaling, and peptide-hormone communication.

01

Regulatory status

A growth hormone releasing factor analogue approved by the FDA in 2010 for a narrow indication in HIV-associated lipodystrophy, set out in detail in regulatory review documents. That approval applies to the licensed pharmaceutical product, not to research material such as this vial.

02

Metabolic and hepatic record

The compound is described as a synthetic growth hormone releasing hormone analogue with major effects on glucose and lipid metabolism. A drug-induced liver injury monograph records that it has not been linked to elevations of serum aminotransferases during therapy, nor to instances of clinically apparent acute liver injury.

03

Trial under current antiretroviral regimens

The phase III programme was conducted before integrase inhibitors became a mainstay of antiretroviral therapy. A randomised double-blind trial of 61 people with HIV and metabolic dysfunction-associated steatotic liver disease was used to evaluate the peptide against identical placebo among participants on integrase inhibitor regimens at baseline, with visceral fat cross-sectional area, hepatic fat fraction and trunk-to-appendicular fat ratio measured by magnetic resonance imaging, proton spectroscopy and dual-energy x-ray absorptiometry.

Tesamorelin holds an FDA approval, and it is narrow: excess visceral adipose tissue in adults with HIV-associated lipodystrophy. It does not extend to body composition or performance use, and a 2026 review of peptides marketed direct to patients treats regulatory status and marketed use as separate questions.

Regulatory status as of October 2026.

Structure

Tesamorelin 10 mg 2D structure

2D structure · PubChem CID 16137828

References

  1. 1 Grunfeld C, Dritselis A, Kirkpatrick P (2011) Tesamorelin. Nat Rev Drug Discov. 10.1038/nrd3362
  2. 2 Russo SC et al. (2024) Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors. AIDS. 10.1097/QAD.0000000000003965
  3. 3 LiverTox (2018) Tesamorelin. LiverTox. PMID 31644039
  4. 4 CADTH (2016) Pharmacoeconomic review report: tesamorelin (Egrifta), Common Drug Reviews. CADTH. PMID 30896905
  5. 5 Mendias CL, Awan TM (2026) Safety and efficacy of approved and unapproved peptide therapies. Sports Med. 10.1007/s40279-026-02437-0
  6. 6 Mayfield CK et al. (2026) Injectable peptide therapy: a primer for orthopaedic and sports medicine physicians. Am J Sports Med. 10.1177/03635465251357593

Common questions

Ordering, handling and compliance. Anything not covered here, write to support@pureforgelabs.com.

What does research use only actually mean?

Every compound we sell is supplied for laboratory research and development only. It is not a drug, not a supplement, and not intended to diagnose, treat, cure or prevent any condition in humans or animals. Buying from this site means you are acquiring it for in vitro or other controlled research work.

Who is allowed to order?

Purchasers must be 21 or older and are responsible for compliance with the law where they take delivery. We ship to research institutions, laboratories and qualified individual researchers in the United States only. We do not ship to jurisdictions where these compounds are restricted.

How do I read the certificate of analysis?

Check three things in order. First, the lot code on the certificate matches the lot listed on the product page and in your order. Second, where the report gives an HPLC purity, its chromatogram shows a single dominant peak at the stated figure; a blend's report shows a peak for each compound. Third, where the lab ran mass spectrometry, the measured mass matches the expected molecular weight of the compound. Anything that does not line up, send us the lot code.

How should it be stored?

Unopened vials keep at ambient temperature short term, as in transit; on arrival, refrigerate them at 2–8 °C, and keep them at −20 °C beyond three months. Reconstitute following your laboratory's own protocol; once in solution, refrigerate at 2–8 °C, protect from light and use within 30 days.

When does it ship and how?

Orders are normally prepared for shipment within 1–3 business days and ship to street addresses in the United States only — not to P.O. boxes or APO/FPO/DPO military addresses. Shipping is free on orders over $150 and a flat $14.95 below that.

What payment methods do you take?

We take credit and debit cards, paid securely at checkout. Bank transfers and purchase orders are not available at the moment.

What if a vial arrives damaged?

Keep the vial and all the packaging, photograph the damage and email support@pureforgelabs.com within 48 hours of delivery with your order number. Once the claim is verified, we replace the vial or refund what you paid for it. Please do not send anything back unless we ask you to — apart from damaged or incorrect items, all sales are final.

Do you handle bulk and wholesale orders?

Yes, by quote. The volume tiers on the product pages go up to five vials; for larger research quantities email support@pureforgelabs.com with the compounds and amounts, and we will quote per gram.

FOR RESEARCH USE ONLY. NOT FOR HUMAN OR VETERINARY CONSUMPTION. This product is intended solely for legitimate laboratory, analytical, and scientific research. It is not intended to diagnose, treat, cure, mitigate, or prevent any disease and is not intended for human or veterinary administration or consumption. All products are intended for research and identification purposes only. These products are not intended for human dosing, injection, or ingestion.

$59.99
Tesamorelin 10 mg · 10 mg · 1 vial

New compounds, restocks, lot releases.

One short email when something changes. No drip campaigns.